Albaugh, Matthew D. http://orcid.org/0000-0002-5971-6658
Owens, Max M. http://orcid.org/0000-0002-5560-4077
Juliano, Anthony
Ottino-Gonzalez, Jonatan
Cupertino, Renata http://orcid.org/0000-0002-3452-0632
Cao, Zhipeng
Mackey, Scott http://orcid.org/0000-0001-7817-7437
Lepage, Claude
Rioux, Pierre
Evans, Alan
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. http://orcid.org/0000-0003-0114-4914
Conrod, Patricia http://orcid.org/0000-0002-5570-481X
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta http://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Gowland, Penny http://orcid.org/0000-0002-4900-4817
Heinz, Andreas http://orcid.org/0000-0001-5405-9065
Ittermann, Bernd
Martinot, Jean-Luc http://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère http://orcid.org/0000-0002-0452-2450
Artiges, Eric http://orcid.org/0000-0003-4461-7646
Nees, Frauke http://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos http://orcid.org/0000-0002-1242-8990
Paus, Tomáš http://orcid.org/0000-0003-1495-9338
Poustka, Luise
Millenet, Sabina
Fröhner, Juliane H. http://orcid.org/0000-0002-8493-6396
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert http://orcid.org/0000-0002-2790-7281
Schumann, Gunter http://orcid.org/0000-0002-7740-6469
Potter, Alexandra
Garavan, Hugh
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K08 MH121654)
Article History
Received: 12 October 2022
Revised: 30 May 2023
Accepted: 16 June 2023
First Online: 28 June 2023
Competing interests
: Dr TB has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. The other authors report no biomedical financial interests or potential competing interests.